{"id":"https://openalex.org/W7225199434","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","title":"942 cDC1-independent tumor rejection: CD45-targeted IL-12 reveals a cDC2\u2013CD4 + T cell axis as a driver of lung tumor immunity","display_name":"942 cDC1-independent tumor rejection: CD45-targeted IL-12 reveals a cDC2\u2013CD4 + T cell axis as a driver of lung tumor immunity","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225199434","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0942"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0942","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1069.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1069.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059282381","display_name":"Brett H. Pogostin","orcid":"https://orcid.org/0000-0002-1462-4442","observed_orcids":["https://orcid.org/0000-0002-1462-4442"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett H Pogostin","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006052464","display_name":"Vidit Bhandarkar","orcid":"https://orcid.org/0000-0002-6526-4360","observed_orcids":["https://orcid.org/0000-0002-6526-4360"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vidit Bhandarkar","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084719758","display_name":"Sean-Luc Shanahan","orcid":"https://orcid.org/0000-0002-8254-0945","observed_orcids":["https://orcid.org/0000-0002-8254-0945"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean-Luc Shanahan","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016588170","display_name":"Molly Carney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Molly Carney","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053400356","display_name":"Taylor A. Heim","orcid":"https://orcid.org/0000-0003-4128-5754","observed_orcids":["https://orcid.org/0000-0003-4128-5754"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taylor Heim","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071936673","display_name":"Tyler Jacks","orcid":"https://orcid.org/0000-0001-5785-8911","observed_orcids":["https://orcid.org/0000-0001-5785-8911"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tyler Jacks","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080569354","display_name":"R. Langer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Langer","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069229817","display_name":"Ana Jaklenec","orcid":"https://orcid.org/0000-0001-6096-0538","observed_orcids":["https://orcid.org/0000-0001-6096-0538"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Jaklenec","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087926553","display_name":"Darrell J. Irvine","orcid":"https://orcid.org/0000-0002-8637-1405","observed_orcids":["https://orcid.org/0000-0002-8637-1405","https://orcid.org/0000-0003-4668-6290"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darrell J Irvine","raw_affiliation_strings":["The Scripps Research Institute, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Scripps Research Institute, La Jolla, CA, USA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013574777","display_name":"Stefani Spranger","orcid":"https://orcid.org/0000-0003-3257-4546","observed_orcids":["https://orcid.org/0000-0003-3257-4546"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefani Spranger","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.93333333,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1069","last_page":"A1070"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdc2","display_name":"cdc2","score":0.6980000138282776},{"id":"https://openalex.org/keywords/myeloid-dendritic-cells","display_name":"myeloid dendritic cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lung-cancer-immunotherapy","display_name":"lung cancer immunotherapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tumor-rejection","display_name":"tumor rejection","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.7400000095367432},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.5669999718666077},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.5090000033378601},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.382999986410141},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.4749999940395355},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6134999990463257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5770000219345093},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5527999997138977},{"id":"https://openalex.org/C3018373657","wikidata":"https://www.wikidata.org/wiki/Q15124212","display_name":"Lung tumor","level":3,"score":0.5004000067710876},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4706000089645386},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.38179999589920044},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32190001010894775},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C3017875465","wikidata":"https://www.wikidata.org/wiki/Q189146","display_name":"Cellular immunity","level":3,"score":0.27160000801086426},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26989999413490295},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2615000009536743},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.25429999828338623}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0942","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1069.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0942","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0942","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1069.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320316943","display_name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","ror":"https://ror.org/01xd6q208"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225199434.pdf","grobid_xml":"https://content.openalex.org/works/W7225199434.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225159671","https://openalex.org/W4415898699","https://openalex.org/W2443796348","https://openalex.org/W1995248820","https://openalex.org/W2124799159","https://openalex.org/W2074185937","https://openalex.org/W2068377409","https://openalex.org/W4308399155","https://openalex.org/W4390972724","https://openalex.org/W2149641471"],"abstract_inverted_index":{"Background":[0],"Interleukin-12":[1],"(IL-12)":[2],"is":[3,23,58,344,364,566],"a":[4,29,222,367,392,569],"potent":[5],"immunostimulatory":[6],"cytokine":[7,47],"produced":[8,106],"by":[9,25,112,131,147,176,366,426,510],"dendritic":[10],"cells":[11,109,303],"(DCs)":[12],"that":[13,54,260,341,547],"primes":[14],"anti-tumor":[15,382],"T":[16,267,289,302,314,328,360,369,388,486,539,553],"cell":[17,43,161,168,315,329,361,370,389,460,487,498,540,554],"responses;":[18],"however,":[19],"its":[20],"clinical":[21],"translation":[22],"hindered":[24],"systemic":[26,342,464],"toxicity":[27],"and":[28,45,80,92,110,115,135,141,165,183,204,220,293,317,384,409,416,440,538],"short":[30],"half-life.":[31],"1":[32],"Using":[33],"antibody-cytokine":[34],"conjugates":[35],"to":[36,39,73,76,84,207,285,311,355,551],"target":[37,395],"IL-12":[38,56,435,528],"CD45":[40,244],"improves":[41],"immune":[42,78,160,167,208],"targeting":[44],"extends":[46],"half-life.2":[48],"While":[49],"previous":[50],"studies":[51],"have":[52],"demonstrated":[53,297],"CD45-targeted":[55],"(\u03b1CD45-IL12)":[57],"highly":[59],"efficacious":[60],"in":[61,98,107,253,275,320,349,380,438,496,556,568],"flank":[62],"tumor":[63,192,217,250,306],"models":[64],"when":[65],"dosed":[66],"intratumorally,2":[67],"lung":[68,100,171,200,351,397,499],"tumors":[69,121,201],"are":[70,81,534],"frequently":[71],"refractory":[72,206],"immunotherapy":[74,348],"due":[75],"tissue-specific":[77],"suppression":[79],"not":[82],"amenable":[83],"intratumoral":[85],"delivery.3":[86],"We":[87,400],"therefore":[88],"investigated":[89],"the":[90,241,254,326,356,386,402,564],"efficacy":[91,271,319,335,363,537,562],"mechanism":[93],"of":[94,180,213,243,264,300,459,484,563],"systemically":[95],"administered":[96],"\u03b1CD45-IL12":[97,215,246,261,309,343],"preclinical":[99],"cancer":[101,172,352,398],"models.Methods":[102],"\u03b1CD45-IL-12":[103],"was":[104,145,154,174,238,272,424],"recombinantly":[105],"HEK293":[108],"purified":[111],"protein":[113],"A":[114,170],"size":[116],"exclusion":[117],"chromatography.":[118],"Syngeneic":[119],"KP.SIY":[120,199],"(Kras":[122],"G12D":[123],"p53\u2212/\u2212":[124],"expressing":[125],"model":[126,184,572],"antigen":[127,185],"SIYRYYGL)":[128],"were":[129,205,508],"established":[130,175],"tail":[132],"vein":[133],"injection":[134],"treated":[136],"intraperitoneally":[137],"on":[138,513],"days":[139],"7":[140],"11":[142],"post-inoculation.":[143],"Immunophenotyping":[144],"performed":[146],"scRNA-Seq,":[148],"flow":[149,294],"cytometry,":[150],"IFN-\u03b3":[151,291],"ELISpot.":[152],"Mechanism":[153],"interrogated":[155],"using":[156],"bone":[157],"marrow":[158],"chimeras,":[159],"KO":[162],"mouse":[163,506,571],"strains,":[164],"antibody-mediated":[166],"depletions.":[169],"GEMM":[173],"intratracheal":[177],"lentiviral":[178],"delivery":[179,458],"Cre":[181],"recombinase":[182],"Rpl18":[186],"into":[187],"KrasG12D/+":[188],"p53fl/fl":[189],"mice,":[190],"with":[191,233],"burden":[193,218,251],"quantified":[194],"histologically":[195],"at":[196],"week":[197],"12.Results":[198],"progressed":[202],"rapidly":[203],"checkpoint":[209,493],"blockade.":[210],"Intraperitoneal":[211],"administration":[212],"low-dose":[214],"reduced":[216,249],"4-fold":[219],"conferred":[221],"significant":[223],"survival":[224],"benefit":[225],"over":[226],"untreated":[227],"mice":[228,277,283,322,557],"(":[229],"figure":[230],"1).":[231],"Treatment":[232],"an":[234,345,375,427],"untargeted":[235],"IgG-IL12":[236],"control":[237],"ineffective,":[239],"demonstrating":[240],"necessity":[242],"targeting.":[245],"treatment":[247,549],"similarly":[248],"2-fold":[252],"KP":[255,305],"GEMM.":[256],"Mechanistic":[257],"analysis":[258,545],"revealed":[259],"enhanced":[262],"activation":[263],"SIY-tetramer+":[265],"CD8+":[266,288,485],"cells.":[268,290],"However,":[269],"therapeutic":[270,334,394],"fully":[273],"preserved":[274],"BATF3\u2212/\u2212":[276],"lacking":[278,323,558,573],"cDC1s":[279],"even":[280],"though":[281],"these":[282],"fail":[284],"prime":[286],"SIY-reactive":[287],"ELISpot":[292,544],"cytometry":[295],"analyses":[296],"robust":[298],"priming":[299,316,491,555],"CD4+":[301,313],"against":[304],"antigens.":[307],"Critically,":[308],"failed":[310],"induce":[312,552],"lost":[318,567],"\u03941+2+3":[321],"cDC2s,":[324],"establishing":[325],"cDC2-CD4+":[327],"axis":[330,390],"as":[331,391],"required":[332,535],"for":[333,378,396,413,419,536],"(figure":[336],"2).Conclusions":[337],"These":[338,372],"findings":[339],"demonstrate":[340],"effective":[346],"single-agent":[347],"checkpoint-refractory":[350],"models.":[353],"Contrary":[354],"canonical":[357],"cDC1\u2013CD8":[358],"+":[359],"paradigm,":[362],"driven":[365],"cDC2\u2013CD4+":[368,387],"axis.":[371],"results":[373],"reveal":[374],"underappreciated":[376],"role":[377],"cDC2s":[379,574],"IL-12-mediated":[381],"immunity":[383],"identify":[385],"novel":[393],"immunotherapy.Acknowledgements":[399],"thank":[401],"Koch":[403],"Institute\u2019s":[404],"Swanson":[405],"Biotechnology":[406],"Core":[407],"Facility":[408],"MIT":[410],"BioMicro":[411],"Center":[412],"technical":[414],"support,":[415],"Lauren":[417],"Duhamel":[418,453],"providing":[420],"immunocytokines.":[421],"This":[422],"work":[423],"supported":[425],"NIH":[428],"K00":[429],"fellowship.References":[430],"Mirlekar":[431],"B,":[432],"Pylayeva-Gupta":[433],"Y.":[434],"Family":[436],"Cytokines":[437],"Cancer":[439],"Immunotherapy.":[441],"Cancers":[442],"2021;13(2):2.Santollani":[443],"L,":[444,446],"Maiorino":[445],"Zhang":[447],"YJ,":[448],"Palmeri":[449],"JR,":[450],"Stinson":[451],"JA,":[452],"LR,":[454],"et":[455,481],"al.":[456,482],"Local":[457],"surface-targeted":[461],"immunocytokines":[462],"programs":[463],"antitumor":[465],"immunity.":[466],"Nat":[467],"Immunol.":[468,502],"2024;25:1820\u20139.Horton":[469],"BL,":[470],"Morgan":[471],"DM,":[472],"Momin":[473],"N,":[474],"Zagorulya":[475],"M,":[476],"Torres-Mejia":[477],"E,":[478],"Bhandarkar":[479],"V,":[480],"Lack":[483],"effector":[488],"differentiation":[489],"during":[490],"mediates":[492],"blockade":[494],"resistance":[495],"non\u2013small":[497],"cancer.":[500],"Sci":[501],"2021;6(64):eabi8800.Ethics":[503],"Approval":[504],"All":[505],"experiments":[507],"approved":[509],"MIT\u2019s":[511],"Committee":[512],"Animal":[514,519],"Care":[515],"(CAC)":[516],"\u2013":[517],"PHS":[518],"Welfare":[520],"Assurance":[521],"#":[522],"D16-00078":[523],"(A3125-01).Abstract":[524],"942":[525,531],"Figure":[526,532],"1CD45-targeted":[527],"enhances":[529],"survivalAbstract":[530],"2cDC2":[533],"priming.":[541],"(A)":[542],"IFNg":[543],"reveales":[546],"immunocytokine":[548,565],"fails":[550],"cDC2s;":[559],"(B)":[560],"Therapuetic":[561],"genetic":[570]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}